Absent FDA Guidance on Sequencing-Based Tests, Personalized Rx Experts Weigh in with Ideas

Published October 17, 2010

Absent FDA Guidance on Sequencing-Based Tests, Personalized Rx Experts Weigh in with Ideas
It’s a given that technology moves faster than regulation, but when it comes to the US Food and Drug Administration’s framework for laboratory-developed tests, the pace of progress has been particularly slow.
Read more on GenomeWeb News

Cardiogenesis Enrolls First Two Patients In Its Feasibility Study Of The PHOENIX® Combination Delivery System
Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, reported the enrollment of the first two patients in its PHOENIX Feasibility Study. Dr. Guillermo Reyes at La Princesa Hospital, Madrid, Spain performed the procedures utilizing the company’s proprietary PHOENIX System that combines the intramyocardial …
Read more on Medical News Today